Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

R&D Market Pulse: Fed Reinforces Plans for September Rate Increase

By R&D Editors | August 27, 2018

The R&D Index for the week ending August 24, 2018 closed at 4,765.49 for the 25 companies in the R&D Index. The Index was up 0.73% (or 34.57 basis points) from the week ending August 17, 2018. Seventeen R&D Index companies gained value last week from 0.07% (GlaxoSmithKline) to 4.58% (Bayer AG). Seven R&D Index companies lost value last week from -0.01% (IBM) to -1.51% (Bristol Myers Squibb). Volkswagen AG was not included in the tabulations last week because the company terminated its sponsored ADR (American Depositary Receipt) program on August 13 while J.P. Morgan established an unsponsored ADS (American Depositary Share) program (VWAGY) on August 14 representing Volkswagen AG’s ordinary shares. Two ADSs were exchanged for every one ADR. VWAGY closed on August 24 at 15.84.

 

The industry group PhRMA (Pharmaceutical Research and Manufacturers of America) last week released its 2018 annual member survey and industry profile indicating that overall R&D spending was at a record high in 2017 of $71.4 billion, up 9% from $65.5 billion in 2016. Of the PhRMA member companies, domestic R&D in 2017 was $55.8 billion with another $15.6 billion spent abroad, revealing a 6.4% increase in domestic spending and a 19.2% increase in R&D spending abroad. The report also revealed that the FDA approved 56 novel drugs in 2017 and that there are more than 1,100 new medicines and vaccines in development for cancer alone.

 

Boeing Aerospace also revealed that it will perform R&D for self-piloting systems and autonomous technologies at a new 100,000-square-foot R&D center at MIT in Cambridge, Mass. (Kendall Square), which is scheduled to open in 2020. The Boeing Aerospace and Autonomy Center will also be the new home of Boeing’s recently purchased Aurora Flight Sciences R&D and will also support Boeing’s creation of NeXt, its next-generation airspace management system. Separately, Boeing also announced it had purchased Millennium Space Systems, El Segundo, California, which produces satellites as small as 50 kg for military and national security applications.

The Federal Reserve’s Chairman Jerome Powell, last week reinforced the Fed’s strategy of gradually raising short-term interest rates against criticisms that the Fed is either moving too slowly or too quickly and thereby jeopardizing the economy’s expansion. This criteria is based on stable inflation and falling unemployment. Powell also reiterated that a third rate increase for 2018 is likely at their meeting in September to a range between 2.00% and 2.25%.

      R&D Index Week Ending August 24, 2018      
    Ticker Exchange 2018 R&D millions U.S. $ 08/17/18 08/24/18 8/24/18 to 8/17/18 8/24/18 to 12/29/17
1 Amazon AMZN NASDAQ 26,750 1,882.22 1,905.39 1.23% 62.93%
2 Alphabet/Google GOOGL NASDAQ 18,796 1,215.85 1,236.75 1.72% 17.41%
3 Apple AAPL NASDAQ 14,037 217.58 216.16 -0.65% 27.73%
4 Intel INTC NASDAQ 13,702 47.10 47.66 1.19% 3.25%
5 Microsoft MSFT NASDAQ 13,558 107.58 108.40 0.76% 26.72%
6 Roche Pharm RHHBY OTC 12,284 30.12 30.58 1.53% -3.17%
7 Johnson & Johnson JNJ NYSE 11,493 134.47 135.95 1.10% -2.70%
8 Merck & Co. MRK NYSE 11,323 69.06 69.04 -0.03% 22.69%
9 Volkswagen AG VWAGY OTC 10,915 32.01 15.84 * -60.83%
10 Toyota TM NYSE 10,848 123.28 122.84 -0.36% -3.40%
11 Novartis NVS NYSE 8,934 83.04 83.75 0.86% -0.25%
12 Honda HMC NYSE 8,180 30.00 29.68 -1.07% -12.91%
13 Pfizer PFE NYSE 7,942 42.09 42.40 0.74% 17.06%
14 Daimler DDAIY OTC 7,615 63.21 63.66 0.71% -24.72%
15 General Motors GM NYSE 7,278 36.38 35.95 -1.18% -12.30%
16 Oracle ORCL NYSE 7,001 48.36 49.26 1.86% 4.19%
17 Bristol-Myers Squibb BMY NYSE 6,981 60.89 59.97 -1.51% -2.14%
18 Eli Lilly Co LLY NYSE 6,769 105.55 105.77 0.21% 25.23%
19 GlaxoSmithKline GSK NYSE 6,394 41.25 41.28 0.07% 16.38%
20 Cisco CSCO NASDAQ 6,009 45.87 46.32 0.98% 20.94%
21 IBM IBM NYSE 5,842 146.06 146.04 -0.01% -4.81%
22 Bayer AG BAYN OTC 5,743 22.73 23.77 4.58% -23.54%
23 Astra Zeneca PLC AZN NYSE 5,483 38.12 38.30 0.47% 10.37%
24 Qualcomm QCOM NASDAQ 5,183 66.06 67.15 1.65% 4.89%
25 Sanofi SA SNY NYSE 4,694 42.04 43.58 3.66% 1.35%
  Total     243,754 4,730.92 4,765.49 1.42% 25.68%
                 
      Biopharmaceutical 669.36 674.39 0.75% 5.75%
      Automotive 284.88 267.97 -5.94% -18.11%
      ICT   1,894.46 1,917.74 1.23% 15.71%

 About the R&D Index

R&D Magazine’s R&D Index is a weekly stock market summary of the top international companies involved in research and development. The top 25 industrial spenders of R&D in 2017 were selected based on the latest listings from Schonfeld & Associates’ June 2018 R&D Ratios & Budgets. These 25 companies include pharmaceutical (11 companies), automotive (5), ICT (8) and conglomerate (1) organizations who invested a cumulative total of more than $209 billion in R&D in 2017, or approximately 10% of all the R&D spent in the world by government, industries and academia combined, according to R&D Magazine’s 2018 Global R&D Funding Forecast. The stock prices used in the R&D Index are tabulated from NASDAQ, NYSE, XETRA and OTC common stock prices (in U.S. dollars) for the companies selected at the close of stock trading business on the Friday preceding the publication of the R&D Index in R&D Magazine’s R&D Daily eNewsletter.

The companies used in the R&D Index include Amazon, Alphabet/Google, Microsoft, Intel, Apple, Volkswagen AG, Roche Pharma, Toyota, Johnson & Johnson, Novartis, General Motors, Pfizer, Bristol-Myers Squibb, Cisco, Qualcomm, Oracle, Honda Motor Company, Astra Zeneca plc, Merck & Company, Daimler, Bayer AG, Sanofi SA, IBM, GlaxoSmithKline and Eli Lilly Co. Stock prices are based on those stocks traded on the U.S. exchanges. R&D Index trends (in the stock prices) are just one indicator of the amount of capital available to these high-technology companies to invest in R&D and should not be implied to indicate the absolute value of R&D investments made by these organizations. The companies chosen for the R&D Index have very large sophisticated internal and global R&D organizations with each company investing between $4.5 and $17 billion annually on their R&D efforts.

Related Articles Read More >

7 major R&D developments this week: Tariff uncertainty persists, Pfizer sells campus, Scania acquires Northvolt unit
economic crisis stock chart falling down business global money bankruptcy concept
7 major R&D developments this week: Tariffs roil markets, MIT wins $12B contract, Siemens plans $5B acquisition
EL SEGUNDO, CA/USA - OCTOBER 13, 2014: Boeing manufactuing facility. Boeing manufactures and sells aircraft, rotorcraft, rockets and satellites. It is the second-largest defense contractor in the world.
8 major R&D moves this week: HHS cuts 10,000 jobs while Anthropic & DataBricks form $100M pact
8 major R&D moves this week: Samsung invests record $24B while Porsche cuts 3,900 jobs
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE